ResearcherHarvard UniversityActive in the last 2 years

Huan Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-7062-6029; OpenAlex author ID A5028979251. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2025: 2 papers

Papers 2

De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer. Co-author DOI 10.1038/s41467-025-61242-x ↗
Unlocking Clinical Insights: Lymphocyte-Specific Protein Tyrosine Kinase Candidates as Promising Therapeutic Targets for Pancreatic Cancer Risk Stratification. Co-author DOI 10.1089/cbr.2024.0056 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wenjie Shi · 1 shared paper, 2025 · strength 0.25
- Paper Unlocking Clinical Insights: Lymphocyte-Specific Protein Tyrosine Kinase Candidates as Promising Therapeutic Targets fo… DOI 10.1089/cbr.2024.0056 ↗
Ulf D. Kahlert · 1 shared paper, 2025 · strength 0.25
- Paper Unlocking Clinical Insights: Lymphocyte-Specific Protein Tyrosine Kinase Candidates as Promising Therapeutic Targets fo… DOI 10.1089/cbr.2024.0056 ↗
Naiara Santana-Codina · 1 shared paper, 2025 · strength 0.20
- Paper De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer. DOI 10.1038/s41467-025-61242-x ↗
Andrew J. Aguirre · 1 shared paper, 2025 · strength 0.20
- Paper De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer. DOI 10.1038/s41467-025-61242-x ↗
Joseph Douglas Mancias · 1 shared paper, 2025 · strength 0.20
- Paper De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer. DOI 10.1038/s41467-025-61242-x ↗
Stephanie K. Dougan · 1 shared paper, 2025 · strength 0.20
- Paper De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer. DOI 10.1038/s41467-025-61242-x ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.